Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Ethylene and auxin hormones interact in complex ways that are essential for plant growth and development.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Acne in children varies by age and severity, requires a pediatric treatment approach, and may need diagnostic evaluation for underlying conditions.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Nanotechnology shows promise for better chronic wound healing but needs more research.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Model improves accuracy in predicting hair loss effects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Low iron and vitamin D levels are linked to hair loss in women.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

The genus Sophora has compounds with potential health benefits and could lead to new drugs, but more research is needed to understand their effects and safety.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires various treatments to prevent this.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.